secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aclaris Therapeutics, Inc. (ACRS)
CIK:        0001557746
Form:       8-K
Filed at:   2024-03-19T23:59:59+00:00
Accession:  0001558370-24-003572
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two Aclaris directors to depart at 2024 annual meeting
------------------------------------------------------

- Director Andrew Powell resigns effective June 6, 2024; no disagreement cited.
- Director Bryan Reasons will not stand for re-election at June 6 annual meeting; no disagreement.
- No replacements announced for the two departing board members.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557746/000155837024003572/0001558370-24-003572-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557746/000155837024003572/acrs-20240314x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-003572

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer